Literature DB >> 21720034

Dissolution-enhancing mechanism of alkalizers in poloxamer-based solid dispersions and physical mixtures containing poorly water-soluble valsartan.

Nam Sung Ha1, Thao Truong-Dinh Tran, Phuong Ha-Lien Tran, Jun-Bom Park, Beom-Jin Lee.   

Abstract

The purpose of this study was to investigate the effects of alkalizers in dissolution rate and crystal structure of valsartan (VAL) in Poloxamer 407 (POX)-based solid dispersions (SD). VAL, a poorly-water soluble drug was selected as a model drug because of its low solubility at low pH. The POX-based SDs containing alkalizers (Na₂CO₃, MgO, meglumine and arginine) were prepared by melting method. The dissolution tests were performed using the United States Pharmacopeia (USP) paddle II method in enzyme-free simulated gastric fluid (pH 1.2) for 2 h. Microenvironmental pH (pH(M)) was examined potentiometrically by using a surface pH electrode. Dissolution rate of SD incorporating Na₂CO₃ was drastically increased. The differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD) data indicated that crystalline structure of VAL in SD was transformed to amorphous form by the addition of alkalizers but could not explain the differences in the dissolution rates. The molecular interaction between VAL and Na₂CO₃ was observed in the Fourier transform infrared spectroscopy (FT-IR) spectra by the shift of C=O band from 1732 to 1719 cm⁻¹ and the disappearance of carbonyl group at 1598 cm⁻¹. Furthermore, Na₂CO₃ efficiently modulated pH(M) by providing a favorable microenvironment for drug dissolution. A combination of SD method and use of alkalizer is a promising approach to modulate release rate of poorly water-soluble and ionizable drug with an aid of changes of drug crystallinity, molecular interaction and pH(M).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21720034     DOI: 10.1248/cpb.59.844

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  5 in total

1.  Development of self-nanoemulsifying drug delivery system for oral bioavailability enhancement of valsartan in beagle dogs.

Authors:  Zhenbao Li; Wenjuan Zhang; Yan Gao; Rongwu Xiang; Yan Liu; Mingming Hu; Mei Zhou; Xiaohong Liu; Yongjun Wang; Zhonggui He; Yinghua Sun; Jin Sun
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

2.  Investigation of the combined effect of MgO and PEG on the release profile of mefenamic acid prepared via hot-melt extrusion techniques.

Authors:  Sultan M Alshehri; Roshan V Tiwari; Bader B Alsulays; Eman A Ashour; Abdullah S Alshetaili; Bjad Almutairy; Jun-Bom Park; Joseph Morott; Bhupinder Sandhu; Soumyajit Majumdar; Michael A Repka
Journal:  Pharm Dev Technol       Date:  2016-01-29       Impact factor: 3.133

3.  The effect of poloxamer 407-based hydrogel on the osteoinductivity of demineralized bone matrix.

Authors:  Jae Hyup Lee; Hae-Ri Baek; Kyung Mee Lee; Hyun-Kyung Lee; Seung Bin Im; Yong Sung Kim; Ji-Ho Lee; Bong-Soon Chang; Choon-Ki Lee
Journal:  Clin Orthop Surg       Date:  2014-11-10

4.  In-Vitro Characterization and Oral Bioavailability of Organic Solvent-free Solid Dispersions Containing Telmisartan.

Authors:  Yue Cao; Li-Li Shi; Qing-Ri Cao; Mingshi Yang; Jing-Hao Cui
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

5.  Preparation and Evaluation of Valsartan Liquid Filling Formulations for Soft Gels.

Authors:  Jyothi Sanaboina; K M Maheswari; Seetha Sunkara; Sravanthi Deekonda; Buchi N Nalluri
Journal:  J Pharm (Cairo)       Date:  2013-01-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.